Why the study?
Oncological surgery is the primary treatment for gynecological malignancies and modern interdisciplinary perioperative care improves outcomes, warranting a review of management strategies.
Answers are grounded in this paper and cite their sources.
Multidisciplinary perioperative care, including ERAS protocols and specialized management for CRS with HIPEC, is essential for improving outcomes in patients undergoing surgery for gynecological malignancies.
Oncological surgery is the primary treatment for gynecological malignancies and is inseparably linked with anesthesia. The modern approach to interdisciplinary and multidisciplinary perioperative care in gynecologic oncological patients improves the outcome. This paper presents a review of perioperative management of patients with gynecologic oncology related to enhanced recovery after surgery and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. We performed a literature search on MEDLINE, EMBASE, Google Scholar, the Cochrane Central Register of Controlled Trials, and Clinical Trials. The database search focused on selected topics related to perioperative gynecological oncology care. The authors also contributed through individual, independent literature searches.
No takes yet. Share an insight, caveat, or question.
Krawczyk et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: